Impaired insulin-stimulated glucose transport in ATM-deficient mouse skeletal muscle

Applied Physiology, Nutrition and Metabolism

Volumn 38, Issue 6, 2013, Pages 589-596

  Ching, James Kain ^a,b   Spears, Larry D ^a,b   Armon, Jennifer L ^a   Renth, Allyson L ^a   Andrisse, Stanley ^a   Collins IV, Roy L ^a   Fisher, Jonathan S ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Akt; AS160; Fiber type; GLUT4; Insulin; Skeletal muscle

Indexed keywords

GLUCOSE; INSULIN;

ANIMAL; METABOLISM; MOUSE; PHOSPHORYLATION; SKELETAL MUSCLE; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; GLUCOSE; INSULIN; MICE; MUSCLE, SKELETAL; PHOSPHORYLATION;

EID: 84878757812     PISSN: 17155312     EISSN: 17155320     Source Type: Journal    
DOI: 10.1139/apnm-2012-0175     Document Type: Article

References (31)

1. Barlow, C., Hirotsune, S., Paylor, R., Liyanage, M., Eckhaus, M., Collins, F., et al. 1996. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell, 86: 159-171. doi:10.1016/S0092-8674(00)80086-0. PMID:8689683.
2. Bhatti, S., Kozlov, S., Farooqi, A.A., Naqi, A., Lavin, M., and Khanna, K.K. 2011. ATM protein kinase: the linchpin of cellular defenses to stress. Cell. Mol. Life Sci. 68: 2977-3006. doi:10.1007/s00018-011-0683-9. PMID:21533982.
3. Blevins, L.S., Jr., and Gebhart, S.S. 1996. Insulin-resistant diabetes mellitus in a black woman with ataxia-telangiectasia. South. Med. J. 89: 619-621. doi:10. 1097/00007611-199606000-00013. PMID:8638204.
4. Burkholder, T.J., Fingado, B., Baron, S., and Lieber, R.L. 1994. Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb. J. Morphol. 221: 177-190. doi:10.1002/jmor.1052210207. PMID:7932768.
5. Ching, J.K., Rajguru, P., Marupudi, N., Banerjee, S., and Fisher, J.S. 2010. A role for AMPK in increased insulin action after serum starvation. Am. J. Physiol. Cell Physiol. 299: C1171-C1179. doi:10.1152/ajpcell.00514.2009. PMID:20810907.
6. Ching, J.K., Luebbert, S.H., Collins, R.L., IV, Zhang, Z., Marupudi, N., Banerjee, S., et al. 2013. Ataxia telangiectasia mutated impacts insulin-like growth factor 1 signalling in skeletal muscle. Exp. Physiol. 98(2): 526-535. doi:10.1113/ expphysiol.2012.066357. PMID:22941977.
7. Defronzo, R.A. 1988. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes, 37: 667-687. PMID:3289989.
8. Delp, M.D., and Duan, C. 1996. Composition and size of type I, IIA, IID/X and IIB fibers and citrate synthase activity of rat muscle. J. Appl. Physiol. 80: 261-270. PMID:8847313.
9. Fisher, J.S., Nolte, L.A., Kawanaka, K., Han, D.H., Jones, T.E., and Holloszy, J.O. 2002. Glucose transport rate and glycogen synthase activity both limit skeletal muscle glycogen accumulation. Am. J. Physiol. Endocrinol. Metab. 282: 1214-1221. doi:10.1152/ajpendo.00254.2001. PMID:12006350.
10. Foley, K., Boguslavsky, S., and Klip, A. 2011. Endocytosis, recycling, and regulated exocytosis of glucose transporter 4. Biochemistry, 50: 3048-3061. doi:10.1021/ bi2000356. PMID:21405107.
11. Halaby, M.J., Hibma, J.C., He, J., and Yang, D.Q. 2008. ATM protein kinase mediates full activation of Akt and regulates glucose transporter 4 translocation by insulin in muscle cells. Cell Signal. 20: 1555-1563. doi:10.1016/j.cellsig.2008. 04.011. PMID:18534819.
12. Hresko, R.C., and Mueckler, M. 2005. mTOR/RICTOR is the Ser473 kinase for Akt/PKB in 3T3-L1 adipocytes. J. Biol. Chem. 280: 40406-40416. doi:10.1074/ jbc.M508361200. PMID:16221682.
13. Hsu, P.P., Kang, S.A., Rameseder, J., Zhang, Y., Ottina, K.A., Lim, D., et al. 2011. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science, 332: 1317-1322. doi: 10.1126/science.1199498. PMID:21659604.
14. Jeong, I., Patel, A.Y., Zhang, Z., Patil, P.B., Nadella, S.T., Nair, S., et al. 2010. Role of ataxia telangiectasia mutated in insulin signaling of muscle-derived cell lines and mouse soleus. Acta Physiol. 198: 465-475. doi:10.1111/j.1748-1716. 2009.02069.x. PMID:20003097.
15. Ju, J.S., Smith, J.L., Oppelt, P.J., and Fisher, J.S. 2004. Creatine feeding increases GLUT4 expression in rat skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 288: E347-E352. doi:10.1152/ajpendo.00238.2004. PMID:15494613.
16. Marchler-Bauer, A., Lu, S., Anderson, J.B., Chitsaz, F., Derbyshire, M.K., DeWeese-Scott, C., et al. 2011. CDD: a Conserved Domain Database for the functional annotation of proteins. Nucleic Acids Res. 39: D225-D229. doi:10. 1093/nar/gkq1189. PMID:21109532.
17. Miles, P., Treuner, K., Latronica, M., Olefsky, J.M., and Barlow, C. 2007. Impaired insulin secretion in a mouse model of Ataxia Telangiectasia. Am. J. Physiol. Endocrinol. Metab 293: E70-E74. doi:10.1152/ajpendo.00259.2006. PMID: 17356010.
18. Oberbach, A., Bossenz, Y., Lehmann, S., Niebauer, J., Adams, V., Paschke, R., et al. 2006. Altered fiber distribution and fiber-specific glycolytic and oxidative enzyme activity in skeletal muscle of patients with type 2 diabetes. Diabetes Care, 29: 895-900. doi:10.2337/diacare.29.04.06.dc05-1854. PMID:16567834.
19. O'Neill, T., Dwyer, A.J., Ziv, Y., Chan, D.W., Lees-Miller, S.P., Abraham, R.H., et al. 2000. Utilization of oriented peptide libraries to identify substrate motifs selected by ATM. J. Biol. Chem. 275: 22719-22727. doi:10.1074/jbc.M001002200. PMID:10801797.
20. Patel, A.Y., McDonald, T.M., Spears, L.D., Ching, J.K., and Fisher, J.S. 2011. Ataxia telangiectasia mutated influences cytochrome c oxidase activity. Biochem. Biophys. Res. Commun. 405: 599-603. doi:10.1016/j.bbrc.2011.01.075. PMID: 21266166.
21. Razani, B., Feng, C., and Semenkovich, C.F. 2010. p53 is required for chloroquineinduced atheroprotection but not insulin sensitization. J. Lipid Res. 51: 1738-1746. doi:10.1194/jlr.M003681. PMID:20208057.
22. Sano, H., Kane, S., Sano, E., Miinea, C.P., Asara, J.M., Lane, W.S., et al. 2003. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J. Biol. Chem. 278: 14599-14602. doi:10.1074/jbc. C300063200. PMID:12637568.
23. Schalch, D.S., McFarlin, D.E., and Barlow, M.H. 1970. An unusual form of diabetes mellitus in ataxia telangiectasia. N. Engl. J. Med. 282: 1396-1402. doi:10.1056/ NEJM197006182822503. PMID:4192270.
24. Schneider, J.G., Finck, B.N., Ren, J., Standley, K.N., Takagi, M., Maclean, K.H., et al. 2006. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab. 4: 377-389. doi:10.1016/j.cmet. 2006.10.002. PMID:17084711.
25. Shulman, G.I., Rothman, D.L., Jue, T., Stein, P., Defronzo, R.A., and Shulman, R.G. 1990. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N. Engl. J. Med. 322: 223-228. doi:10.1056/NEJM199001253220403. PMID:2403659.
26. Smith, J.L., Ju, J.S., Saha, B.M., Racette, B.A., and Fisher, J.S. 2004. Levodopa with carbidopa diminishes glycogen concentration, glycogen synthase activity, and insulin-stimulated glucose transport in rat skeletal muscle. J. Appl. Physiol. 97: 2339-2346. doi:10.1152/japplphysiol.01219.2003. PMID:15258132.
27. Treebak, J.T., Taylor, E.B., Witczak, C.A., An, D., Toyoda, T., Koh, H.J., et al. 2010. Identification of a novel phosphorylation site on TBC1D4 regulated by AMPactivated protein kinase in skeletal muscle. Am. J. Physiol. Cell Physiol. 298: C377-C385. doi:10.1152/ajpcell.00297.2009. PMID:19923418.
28. Viniegra, J.G., Martinez, N., Modirassari, P., Losa, J.H., Parada, C.C., Lobo, V.J., et al. 2005. Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM. J. Biol. Chem. 280: 4029-4036. doi:10. 1074/jbc.M410344200. PMID:15546863.
29. Wang, Y., Ding, S.J., Wang, W., Jacobs, J.M., Qian, W.J., Moore, R.J., et al. 2007. Profiling signaling polarity in chemotactic cells. Proc. Natl. Acad. Sci. U.S.A. 104: 8328-8333. doi:10.1073/pnas.0701103104. PMID:17494752.
30. Yang, D.Q., and Kastan, M.B. 2000. Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat. Cell Biol. 2: 893-898. doi:10.1038/35046542. PMID:11146653.
31. Yang, D.Q., Halaby, M.J., Li, Y., Hibma, J.C., and Burn, P. 2011. Cytoplasmic ATM protein kinase: an emerging therapeutic target for diabetes, cancer and neuronal degeneration. DrugDiscov. Today,16: 332-338. doi:10.1016/j.drudis.2011. 02.001. PMID:21315178.